At 11:30 AM, the S&P BSE Sensex added 46.17 points or 0.06% to reach 77,142.65, while the Nifty 50 index rose 12.15 points or 0.05% to 24,114.40, according to Business Standard reports. The broader market outperformed with the BSE 150 MidCap Index adding 0.13% and the BSE 250 SmallCap Index jumping 0.24%. Market breadth remained positive with 2,606 shares rising against 1,794 shares falling on the BSE, while 216 shares remained unchanged. The Nifty traded above the 24,100 level during the session.
Turtlemint Fintech Solutions received bids for 1,81,37,056 shares against 3,29,01,878 shares on offer, resulting in a 0.55 times subscription as of 11:22 AM on June 23, 2026, according to Business Standard reports. The IPO opened for bidding on June 19, 2026, and will close on June 23, 2026, with a price band fixed between ₹144 and ₹152 per share. Waterways Leisure Tourism was subscribed 0.06 times with bids for 2,45,214 shares against 41,84,004 shares on offer, while Advit Jewels achieved a 2.76 times subscription with bids for 2,30,88,300 shares against 83,79,300 shares offered. Growth in India's eight core industrial sectors slowed to 0.5% in May 2026, marking the second-lowest level in 21 months, according to official data released by the Ministry of Commerce and Industry on June 22, 2026.
India's manufacturing and services sectors showed signs of moderation in June 2026, with the HSBC Manufacturing PMI easing to 54.5 from 55.0 in the previous month, indicating a slowdown in factory activity while remaining in expansion territory, as reported by Business Standard. The Services PMI declined to 57.3 in June from 59.8 earlier, reflecting a moderation in service sector growth. Consequently, the Composite PMI fell to 57.4 in June compared with 59.3 in the previous reading, signalling a softer but continued expansion in overall private sector activity. This moderation comes amid broader concerns about rising expectations the Federal Reserve may take more aggressive action to tackle inflation later this year, with Asian markets trading lower as investors grappled with these expectations.
The Nifty Pharma index rose 1.72% to 25,188.25, adding 4.31% over four consecutive trading sessions, according to Business Standard reports. Key gainers included Piramal Pharma (up 8.01%), Laurus Labs (up 3.04%), Zydus Lifesciences (up 2.89%), Cipla (up 2.86%), and Gland Pharma (up 2.2%). Other notable performers included Ipca Laboratories (up 2.11%), Biocon (up 1.95%), Alkem Laboratories (up 1.92%), Aurobindo Pharma (up 1.88%), and Sun Pharmaceutical Industries (up 1.62%). The sector's continued outperformance comes despite broader market concerns about manufacturing and services sector slowdown.
Bharat Electronics (BEL) rose 0.80% after securing additional orders worth ₹1,081 crore since its last disclosure on May 25, 2026, according to Business Standard reports. Birla Corporation added 1.12% following the announcement of commencement of commercial production of coal at Bikram Coal Mine effective June 22, 2026. DEE Development Engineers (DDEL) fell 0.20% after its wholly owned subsidiary secured an order worth ₹64 crore from Ganeko Solar for windmill towers supply. Oil prices continued to edge lower as supply concerns eased after U.S. Vice President JD Vance said progress had been made in talks with Iran and that the Strait of Hormuz was open.
